Loading…
Researchers at the Icahn School of Medicine at Mount Sinai reported the first complete structure of the human AASS enzyme, which breaks down lysine. The study in Science Advances identified a flexible regulatory region where small changes can alter enzyme activity.
This is a laboratory-stage human health finding with no bearing on feed supply, demand or prices. It does not change the outlook for lysine or other feed ingredients.
gsmglobalnews.comGSMNov 15, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
